IBM (IBM)

NYSEInformation TechnologyInformation Technology ServicesSnapshot 2026-09-04

$234.89+0.08%

Close 2026-09-04 · 1-day change

Standing thesis

The standing, falsifiable read: what has to stay true, and what would break it.

Compounder

Broken: Primary pillar broken — Achieve over 5% revenue growth: FY26 rev +4.5% vs 5%.

The bull case

IBM is growing revenue about 9% year over year. It aims for over 5% revenue growth annually. The company invests $10 billion in quantum computing over five years. Profit margins and free cash flow remain solid.

The bear case

IBM's revenue declined from $19.7B in Q4 2025 to $15.9B in Q1 2026. The company is behind its 5% revenue growth target. Legal and capital allocation issues may pressure financials. Valuation is stretched versus peers.

What's priced in

The price is about 26% above our fair value near $242 and 21% below the Street median of $305. Analysts expect about 5.5% revenue growth, slightly above IBM's target but below recent beats. Our view is more cautious on growth sustainability.

What has to stay true

Generate free cash flow of at least $14BBroken
Cash FlowsupportingFree cash flow >= $14B in FY25 · FY25 (guidance)
Breaks if: Free cash flow falls below $14B in FY25
Maintain or improve profit marginsIntact
MarginsupportingOperating margin >=1% in FY25 · FY25 (guidance)
Breaks if: Operating margin falls below 1% in FY25
Invest over $10B in quantum computing over 5 yearsIntact
Competitive MoatsupportingInvest $10B+ in quantum by 2030 · next 5 years (qualitative)
Breaks if: Investment in quantum falls significantly short of $10B over 5 years

Source: QuarterlyIQ research model· Written 2026-07-08· Health checked 2026-09-04· Version 1· Status: Broken· Reviewed when the evidence changes

This is not a price target or investment advice.

Current Outlook

Week of Sep 5, 2026

A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.

IBM's long-term thesis is supported by strong recent financial performance and management's growth priorities.

What kind of bet this is

This investment represents a durable compounder with a focus on revenue growth and strategic investments. The current thesis state is intact, reflecting confidence in management's execution and ongoing momentum in financial results.

What's priced into IBM

The market currently prices IBM with a durable premium compared to its peers, indicating that investors expect solid performance. There is a small expectations gap, suggesting that while the stock is viewed positively, there is room for growth in investor sentiment.

What the fundamentals likely do

Management is on track to achieve its revenue growth target of over 5% annually, with recent revenue increases supporting this goal. Free cash flow remains flat, but management's commitment to a year-over-year increase indicates potential for improvement.

What IBM hinges on

The long-term thesis hinges on key factors such as guidance from management in upcoming calls, potential Federal Reserve rate cuts, and performance from sector peers. Any negative guidance could impact sentiment, while positive developments in the tech sector could provide a boost.

What changed in the latest read

What changed

The most important moves since the prior daily snapshot.

Short-term · Daily

No material changes since the prior snapshot.

Yes, our read has strengthened. IBM plans to invest over $10 billion in quantum computing. This investment supports its long-term growth strategy. The company also aims to expand its AI and hybrid cloud software portfolio. No new threats have emerged that weaken this outlook.

as of 2026-09-04

See upcoming information that could change the risk

Review the evidence to watch, what would become a concern, and what would make it less concerning.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.